B-COMPASS: Pilot sites

B-COMPASS: Pilot sites

Validation of B-COMPASS Throughout 2025-2026

To evaluate the effectiveness of B-COMPASS, comprehensive validation studies have been running since 2025 and are still on-going. As a disease-agnostic model, B-COMPASS is currently tested across six therapeutic areas: cardiovascular, endocrinology, immunology, neurology, oncology, and rare diseases, engaging both patients and healthcare professionals.

Twelve pilot sites in seven countries will collect data to assess how B-COMPASS supports patients and enhances treatment adherence.

List of pilot Sites

Akershus University Hospital and the University of Oslo
Associacao Protectora dos Diabeticos de Portugal
Foundation for Biomedical Research and Innovation in Primary Care of Madrid
Foundation for Biomedical Research of University Pediatric Hospital Niño Jesús of Madrid
Heinrich-Heine University Düsseldorf
Italian Multiple Sclerosis Foundation
Jordi Gol i Gurina University Institute for Primary Health Care Research Foundation
Kilimanjaro Clinical Research Institute
Serviços em Medicina, Educação, Investigação, Desenvolvimento e Avaliação
Tilburg University
University Medical Centre Maribor
World Duchenne Organization